Nektar Therapeutics
NKTR
#4629
Rank
S$2.61 B
Marketcap
S$91.24
Share price
-1.54%
Change (1 day)
469.07%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : S$0.24 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are S$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$0.24 B-25.96%
2024-12-31S$0.33 B-6.3%
2023-12-31S$0.35 B-23.51%
2022-12-31S$0.46 B-22.07%
2021-12-31S$0.59 B-3.08%
2020-12-31S$0.61 B-20.83%
2019-12-31S$0.77 B30.48%
2018-12-31S$0.59 B4.95%
2017-12-31S$0.56 B-19.06%
2016-12-31S$0.69 B-0.07%
2015-12-31S$0.69 B30.01%
2014-12-31S$0.53 B-19.4%
2013-12-31S$0.66 B20.53%
2012-12-31S$0.55 B4.14%
2011-12-31S$0.52 B-4.56%
2010-12-31S$0.55 B-16.51%
2009-12-31S$0.66 B25.41%
2008-12-31S$0.52 B-27.92%
2007-12-31S$0.73 B-11.44%
2006-12-31S$0.82 B-6.28%
2005-12-31S$0.88 B95.51%
2004-12-31S$0.45 B-41.11%
2003-12-31S$0.76 B10.83%
2002-12-31S$0.69 B-5.57%
2001-12-31S$0.73 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$151.27 B 61,642.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$156.05 B 63,594.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$105.32 B 42,890.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$17.93 B 7,221.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$108.25 B 44,084.41%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$84.02 B 34,193.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$55.65 M-77.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$0.85 B 250.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland